Source: https://www.nysenate.gov/legislation/bills/2017/s5357/amendment/a
Timestamp: 2019-11-19 17:54:37
Document Index: 745890765

Matched Legal Cases: ['§ 3306', '§ 812', '§ 3306', '§ 812', '§ 3306', '§ 3306', '§ 812', '§ 3306', '§ 812', '§ 3306', '§ 812', '§ 3306', '§ 812', '§ 3306', '§ 3306', '§ 3306', '§ 3306', '§ 3306', '§ 812', '§ 2', '§ 812', '§  3', '§  4', '§ 812', '§ 5', '§ 812', '§  6', '§ 812', '§  7', '§  812', '§  8', '§  9', '§ 10', '§ 11', '§  12', '§ 13', '§ 3306', '§ 3306', '§ 3306', '§ 3306', '§ 3306', '§\n3306', '§ 3306', '§  2', '§  3', '§  4', '§ 5', '§ 6', '§  7', '§  8', '§  9', '§ 10']

NY State Senate Bill S5357A
senate Bill S5357A
Relates to adding substances to the various schedules of controlled substances
Get Status Alerts for S5357A
Jun 19, 2017 amended on third reading 5357a
Jun 19, 2017 vote reconsidered - restored to third reading
Jun 13, 2017 referred to health
May 23, 2017 1st report cal.1147
Mar 22, 2017 referred to health
S5357
S5357 - Details
S5357 - Summary
Provides for the express addition and addition by reference of numerous controlled substances to the state schedules of controlled substances.
S5357 - Sponsor Memo
BILL NUMBER:  S5357
to adding substances to the schedules of controlled substances
This bill would update the State controlled substances schedules,
promoting consistency with the federal schedules and promoting health
Section 1 of the bill would add a synthetic opioid analgesic; often
known as AH-7921, and seven fentantyl analogs to Schedule I(b) of
Public Health Law (PHL) § 3306. The section would also add any
controlled substance listed in 21 U.S.C. § 812, Schedule I(a), that is
not otherwise listed in state Schedule 1(b) to such schedule.
Section 2 of the bill would amend PHL § 3306, Schedule I(c) to add the
controlled substances listed in 21 U.S.C. § 812, Schedule I(b), if not
already listed therein.
Section 3 of the bill would amend PHL § 3306, Schedule I(d) to correct
the spelling of ibogane.
Section 4 of the bill would add a number of substances to PHL § 3306,
Schedule I(d). Additionally, the section would add the controlled
substances listed in 21 U.S.C. § 812, Schedule I(c) or (d), if not
Section 5 of the bill would amend PHL § 3306, Schedule I(e), to add
the controlled substances listed in 21 U.S.C. § 812, Schedule III(b)
or IV, if not already listed therein.
Section 6 would amend PHL § 3306, Schedule II(c), to add the
controlled substances listed in 21 U.S.C. § 812, Schedule II, Schedule
III(d) or Schedule V, if not already listed therein.
Section 7 would amend PHL § 3306, Schedule II(d) to add the controlled
substances listed in 21 U.S.C. § 812, Schedule III(a), if not already
Section 8 of the bill would amend PHL § 3306, Schedule II (h) to add
methasterone and prostanozol.
Section 9 of the bill would amend PHL § 3306, Schedule III (c) to add
Section 10 of the bill would amend PHL § 3306, Schedule IV (c) to add
alfaxalone and suvorexant.
Section 11 of the bill would amend PHL § 3306, Schedule IV(f) to
clarify that the inclusion of salts and isomers applies whenever such
salts or isomers are possible within the specific chemical designation
of a substance. The section also would add lorcaserin and eluxadoline
to Schedule IV(f).
Section 12 of the bill would amend PHL § 3306, Schedule V(d) to add
brivaracetam.
Section 13 would set forth the effective date.
This bill would update the New York State controlled substances
schedules to conform to the current federal schedules of controlled
substances. Individuals often exploit the fact that certain drugs
classified as controlled substances under federal law are not
similarly classified as controlled substances under New York law, and
thus are more easily diverted. Consistency between the State and
federal schedules is therefore important to address the prevalence of
abuse and misuse of controlled substances. At the same time, the State
should not wait for final federal action when it appears that a
substance is dangerous and should be scheduled.
The bill would further add several fentantyl analogs, including some
which are temporarily listed in the federal schedule. This is
consistent with a recommendation made by the Heroin and Opioid Task
Force, convened by the Governor to identify ways to address the
ongoing crisis of heroin and opioid addiction. In making this
recommendation, the Task Force noted that fentanyl is more potent than
heroin but has been found mixed with and sold as heroin, which can be
particularly dangerous. Adding these precursors to the schedule also
would eliminate a loophole which otherwise might allow drug dealers to
The bill would also add other known dangerous substances to the State
schedule of controlled substances, including a synthetic opioid
analgesic, often is known as AH-7921, which can cause a psychoactive
reaction and has led to a number of deaths within the United States
and other counties. Finally, the bill would clarify that the inclusion
of salts and isomers applies whenever such salts or isomers are
possible within the specific chemical designation of a substance.
90 days, succeeding enactment.
S5357 - Bill Text download pdf
Introduced by Sen. HANNON -- (at request of the Department of Health) --
AN ACT to amend the public health law, in relation to adding  substances
to the schedules of controlled substances
Section 1. Subdivision (b) of schedule I of section 3306 of the public
health law is amended by adding nine new paragraphs 56, 57, 58, 59,  60,
61, 62, 63 and 64 to read as follows:
(56) 3,4-DICHLORO-N-{(1-DIMETHYLAMINO)CYCLOHEXYLMETHYL}BENZAMIDE. SOME
TRADE OR OTHER NAMES: AH-7921.
(57) N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENLYACETAMIDE   (ACETYL  FENTA-
NYL).
(58) -(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLBUTYRAMIDE  (BUTYRYL  FENTA-
(59) N-{1-{2-HYDROXY-2-(THIOPHEN-2-YL)ETHYL}PIPERIDIN-4-YL}- N-PHENYL-
PROPIONAMIDE (BETA-HYDROXYTHIOFENTANYL).
(60) N-(1-PHENETHYLPIPERDIN-4-YL)-N-PHENYLFURAN-2-CARBOXAMIDE (FURANYL
FENTANYL).
(61) N-PHENYL-N-{1-(2-PHENYLETHYL)-4-PIPERIDINYL}-PENTANAMIDE (VALERYL
FENTANYL, PENTANOYL FENTANYL, PENTANYL FENTANYL).
(62) U-47700(3,4-DICHLORO-N-(2-(DIMETHYLAMINO)CYCLOHEXYL)-N-METHYL-BEN-
ZAMIDE)YL.
(63) 4-CHLORO-N-{1-{2-(4-NITROPHENYL)ETHYL}-2-PIPERIDINYLIDENE}-BENZENE-
SULFONAMIDE (W18).
(64)  ANY  CONTROLLED  SUBSTANCE  LISTED  IN 21 U.S.C. § 812, SCHEDULE
I(A), THAT IS NOT OTHERWISE LISTED IN THIS SCHEDULE.
§ 2. Subdivision (c) of schedule I  of  section  3306  of  the  public
health law, is amended by adding a new paragraph 24 to read as follows:
LBD10140-01-7
S. 5357                             2
(24)  ANY  CONTROLLED  SUBSTANCE  LISTED  IN 21 U.S.C. § 812, SCHEDULE
I(B), THAT IS NOT OTHERWISE LISTED IN THIS SCHEDULE.
§  3. Paragraph 11 of subdivision (d) of schedule I of section 3306 of
the public health law, as added by chapter 664 of the laws of  1985,  is
(11) [Ibogane]  IBOGAINE Some trade and other names: 7-ethyl-6, 6&, 7,
8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido  {1',2':1,2}
azepino {5,4-b} indole: tabernanthe iboga.
§  4.  Subdivision  (d)  of  schedule  I of section 3306 of the public
health law is amended by adding twenty-one new paragraphs  36,  37,  38,
39,  40,  41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55 and
56 to read as follows:
(36) 5-METHOXY-N,N-DIMETHYLTRYPTAMINE.
(37) ALPHA-METHYLTRYPTAMINE. SOME TRADE OR OTHER NAMES: AMT.
(38) 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE. SOME TRADE OR  OTHER  NAMES:
5-MEO-DIPT.
(39) 5-(1,1-DIMETHYLHEPTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
SOME TRADE OR OTHER NAMES: CP-47,497.
(40)     5-(1,1-DIMETHYLOCTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
SOME TRADE OR OTHER NAMES: CANNABICYCLOHEXANOL OR CP-47,497 C8-HOMOLOG.
(41)  1-BUTYL-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR   OTHER   NAMES:
JWH-073.
(42)   1-HEXYL-3-(1-NAPHTHOYL)INDOLE.   SOME  TRADE  OR  OTHER  NAMES:
JWH-019.
(43) 1-{2-(4-MORPHOLINYL)ETHYL}-3-(1-NAPHTHOYL)INDOLE. SOME  TRADE  OR
OTHER NAMES: JWH-200.
(44)  1-PENTYL-3-(2-METHOXYPHENYLACETYL)INDOLE.  SOME  TRADE  OR OTHER
NAMES: JWH-250.
(45) 1-PENTYL-3-{1-(4-METHOXYNAPHTHOYL)}INDOLE. SOME  TRADE  OR  OTHER
NAMES: JWH-081.
(46)  1-PENTYL-3-(4-METHYL-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
NAMES:  JWH-122.
(47)  1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
NAMES:  JWH-398.
(48)  1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR OTHER
NAMES: AM2201.
(49) 1-(5-FLUOROPENTYL)-3-(2-IODOBENZOYL)INDOLE. SOME TRADE  OR  OTHER
NAMES: AM694.
(50)   1-PENTYL-3-{(4-METHOXY)-BENZOYL}INDOLE.  SOME  TRADE  OR  OTHER
NAMES: SR-19 AND RCS-4.
(51) 1-CYCLOHEXYLETHYL-3-(2-METHOXYPHENYLACETYL)INDOLE. SOME TRADE  OR
OTHER NAMES: SR-18 AND RCS-8.
(52)  1-PENTYL-3-(2-CHLOROPHENYLACETYL)INDOLE.  SOME  TRADE  OR  OTHER
NAMES:  JWH-203.
(53)  (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)  METHA-
NONE. SOME TRADE OR OTHER NAMES: UR-144.
{1-(5-FLUORO-PENTYL)-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)
METHANONE. SOME TRADE OR OTHER NAMES: 5-FLUORO-UR-144,XLR11.
(55) N-(1-ADAMANTYL)-1-PENTLY-1H-INDAZOLE-3-CARBOXAMIDE. SOME TRADE OR
OTHER NAMES: APINACA, AKB 48.
(56)  ANY  CONTROLLED  SUBSTANCE  LISTED IN 21 U.S.C. § 812, SCHEDULES
I(C) OR I(D), THAT IS NOT OTHERWISE LISTED IN THIS SCHEDULE.
§ 5. Subdivision (e) of schedule I  of  section  3306  of  the  public
health law is amended by adding a new paragraph 25 to read as follows:
S. 5357                             3
(25)  ANY  CONTROLLED  SUBSTANCE  LISTED IN 21 U.S.C. § 812, SCHEDULES
III(B) OR IV, THAT IS NOT OTHERWISE LISTED IN THIS SECTION.
§  6.  Subdivision  (c)  of  schedule II of section 3306 of the public
health law is amended by adding a new paragraph 29 to read as follows:
(29) ANY CONTROLLED SUBSTANCE LISTED IN 21 U.S.C. § 812 SCHEDULES  II,
III(D) OR V, THAT IS NOT OTHERWISE LISTED IN THIS SECTION.
§  7.  Subdivision  (d)  of  schedule II of section 3306 of the public
health law is amended by adding a new paragraph 6 to read as follows:
(6) ANY CONTROLLED SUBSTANCE LISTED  IN  21  U.S.C.  §  812,  SCHEDULE
III(A), THAT IS NOT OTHERWISE LISTED IN THIS SECTION.
§  8.  Subdivision  (h)  of  schedule II of section 3306 of the public
health law is amended by adding two new paragraphs 64 and 65 to read  as
(64) METHASTERONE (2{ALPHA}17{ALPHA}-DIMETHYL-5{ALPHA}-ANDROSTAN-
17{BETA}-OL-3-ONE).
(65) PROSTANOZOL (17{BETA}-HYDROXY-5{ALPHA}-ANDROSTANO{3,2-C}PYRAZOLE).
§  9.  Subdivision  (c)  of schedule III of section 3306 of the public
health law, is amended by adding a new paragraph 15 to read as follows:
(15) PERAMPANEL.
§ 10. Subdivision (c) of schedule IV of section  3306  of  the  public
health  law is amended by adding two new paragraphs 54 and 55 to read as
(54) ALFAXALONE.
(55) SUVOREXANT.
§ 11. Subdivision (f) of schedule IV of section  3306  of  the  public
health  law, as added by chapter 664 of the laws of 1985, paragraph 2 as
added by chapter 457 of the laws of 2006 and paragraph  3  as  added  by
section  14  of part C of chapter 447 of the laws of 2012, is amended to
(f) Other substances. Unless specifically excepted or unless listed in
another schedule, any material, compound, mixture or  preparation  which
contains  any quantity of the following substances, including its salts,
ISOMERS, AND SALTS, OF SUCH ISOMERS,  WHENEVER  THE  EXISTENCE  OF  SUCH
SALTS, ISOMERS, AND SALTS OF ISOMERS IS POSSIBLE:
(1) Pentazocine.
(4) LORCASERIN.
(5) ELUXADOLINE.
§  12.  Subdivision  (d)  of  schedule V of section 3306 of the public
health law is amended by adding a new paragraph 4 to read as follows:
(4) BRIVARACETAM.
§ 13. This act shall take effect on the ninetieth day after  it  shall
S5357A (ACTIVE) - Details
S5357A (ACTIVE) - Summary
S5357A (ACTIVE) - Sponsor Memo
BILL NUMBER:  S5357A
The purpose of this bill is to update the State controlled substances
schedules, promoting consistency with the federal schedules, and
Section 1 of the bill adds a synthetic opioid analgesic, often known
as AH-7921, and one fentanyl analog, Acetyl Fentanyl, to Schedule I(b)
of Public Health Law (PHL) § 3306, to conform with the federal
Section 2 of the bill would amend Schedule 1(d) of PHL§ 3306 to
correct the spelling of ibogaine and to add a technical correction.
Section 3 of the bill would add several substances to Schedule 1(d) of
PHL§ 3306, to conform with the federal schedule.
Section 4 of the bill would add the substance thiafentanil to Schedule
I1(c) of PHL§ 3306, to conform with the federal schedule.
Section 5 of the bill would add methasterone and prostanozol to
Schedule II(h) of PHL§ 3306, to conform with the federal schedule.
Section 6 of the bill would add perampanel to Schedule III(c) of PHL§
3306, to conform to the federal schedule.
Section 7 of the bill would add alfaxalone and suvorexant to Schedule
IV(c) of PHL§ 3306, to conform with the federal schedule.
Section 8 of the bill would amend the opening paragraph of Schedule
IV(f) to clarify the inclusion of salts and isomers. The section also
would add lorcaserin and eluxadoline to the schedule, to conform to
the federal schedule.
Section 9 of the bill would add brivaracetam to Schedule V(d) of PHL§
Section 10 sets forth the effective date.
Drug-seeking individuals often exploit the fact that certain drugs
controlled substances under New York law and are more easily diverted.
Consistency between the New York State and federal schedule is
therefore important to address the prevalence of abuse and misuse of
This bill would add a fentanyl analog, consistent with a
recommendation made by the Heroin and Opioid Task Force, convened by
the Governor to identify ways to address the ongoing crisis of heroin
and opioid addiction. In making this recommendation, the Task Force
noted that fentanyl is more potent than heroin but has been found
mixed with and sold as heroin, which can be particularly dangerous.
The bill also adds other known dangerous substances to the schedule of
controlled substances, including a synthetic opioid analgesic, often
is known as AH-7921, which can cause a psychoactive reaction and has
led to a number of deaths within the United States and other counties;
methasterone and prostanozol, both considered to be "designer
steroids;" perampanel, a drug which can be effective in blocking
seizures but may have strong hallucinogenic and depressant effects and
other drugs which have abuse potential which are already scheduled by
Finally, the bill clarifies that the inclusion of salts and isomers
applies within the specific chemical designation of a substance.
S5357A (ACTIVE) - Bill Text download pdf
5357--A
Cal. No. 1147
Introduced  by  Sens. HANNON, GALLIVAN, HELMING, LARKIN, MURPHY, O'MARA,
RANZENHOFER, RITCHIE -- (at request of the Department  of  Health)  --
the Committee on Health -- reported  favorably  from  said  committee,
AN  ACT to amend the public health law, in relation to adding substances
health  law is amended by adding two new paragraphs 56 and 57 to read as
(57)  N-(1-PHENETHYLPIPERIDIN-4-YL)-N-PHENYLDECTAMIDE  (ACETYL  FENTA-
§  2. Paragraph 11 of subdivision (d) of schedule I of section 3306 of
(11)  [Ibogane] IBOGAINE Some trade and other names: 7-ethyl-6, 6&, 7,
8, 9, 10, 12, 13-octahydro-2-methoxy-6,  [9-methano-5h-pyrido]  9-METHA-
NO-5H-PYRIDO {1',2':1,2} azepino {5,4-b} indole: tabernanthe iboga.
§  3.  Subdivision  (d)  of  schedule  I of section 3306 of the public
health law is amended by adding thirty-five new paragraphs 36,  37,  38,
39,  40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56,
57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, and 70  to  read  as
LBD10140-09-7
S. 5357--A                          2
(38) 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE.  SOME  TRADE OR OTHER NAMES:
(40) 5-(1,1-DIMETHYLOCTYL)-2-{(1R,3S)-3-HYDROXYCYCLOHEXYL}-PHENOL.
(41) 1-BUTYL-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE   OR   OTHER   NAMES:
(42) 1-HEXYL-3-(1-NAPHTHOYL)INDOLE.   SOME   TRADE   OR  OTHER  NAMES:
(44) 1-PENTYL-3-(2-METHOXYPHENYLACETYL)INDOLE.  SOME  TRADE  OR  OTHER
(46) 1-PENTYL-3-(4-METHYL-1-NAPHTHOYL)INDOLE.   SOME  TRADE  OR  OTHER
(47) 1-PENTYL-3-(4-CHLORO-1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR   OTHER
(48) 1-(5-FLUOROPENTYL)-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR  OTHER
(50) 1-PENTYL-3-{(4-METHOXY)-BENZOYL}INDOLE.   SOME   TRADE  OR  OTHER
(52) 1-PENTYL-3-(2-CHLOROPHENYLACETYL)INDOLE.   SOME  TRADE  OR  OTHER
(53) (1-PENTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)   METHA-
(54) {1-(5-FLUORO-PENTYL)-1H-INDOL-3-YL}(2,2,3,3-TETRAMETHYLCYCLOPROPYL)
(55) N-(1-ADAMANTYL)-1-PENTYL-1H-INDAZOLE-3-CARBOXAMIDE. SOME TRADE OR
(56) QUINOLIN-8-YL  1-PENTYL-1H-INDOLE-3-CARBOXYLATE.  SOME  TRADE  OR
OTHER NAMES: PB-22 AND QUPIC.
(57) QUINOLIN-8-YL 1-(5-FLUOROPENTYL)-1H-INDOLE-3-CARBOXYLATE.    SOME
TRADE OR OTHER NAMES: 5-FLUORO-PB-22 AND 5F-PB-22.
(58) N-(1-AMINO-3-METHYL-1-OXOBUTAN-2-YL)-1-(4-FLUOROBENZYL)- 1H-INDA-
ZOLE-3-CARBOXAMIDE. SOME TRADE OR OTHER NAMES: AB-FUBINACA.
(59) N-(1-AMINO-3,3-DIMETHYL-1-OXOBUTAN-2-YL)-1-PENTYL-1H-
INDAZOLE-3-CARBOXAMIDE. SOME TRADE OR OTHER NAMES: ADB-PINACA.
(60) 4-METHYL-N-ETHYLCATHINONE. SOME TRADE OR OTHER NAMES:  4-MEC.
(61) 4-METHYL-ALPHA-PYRROLIDINOPROPIOPHENONE.   SOME  TRADE  OR  OTHER
NAMES: 4-MEPPP.
(62) ALPHA-PYRROLIDINOPENTIOPHENONE. SOME TRADE OR OTHER NAMES: 2-PVP.
(63) 1-(1,3-BENZODIOXOL-5-YL)-2-(METHYLAMINO)BUTAN-1-ONE.  SOME  TRADE
OR OTHER NAMES: BUTYLONE AND BK-MBDB.
(64) 2-(METHYLAMINO)-1-PHENYLPENTAN-1-ONE.  SOME TRADE OR OTHER NAMES:
PENTEDRONE.
(65) 1-(1,3-BENZODIOXOL-5-YL)-2-(METHYLAMINO)PENTAN-1-ONE.  SOME TRADE
OR OTHER NAMES: PENTYLONE AND BK-MBDP.
S. 5357--A                          3
(66) 4-FLUORO-N-METHYLCATHINONE. SOME TRADE OR OTHER NAMES:  4-FMC AND
(67) 3-FLUORO-N-METHYLCATHINONE. SOME TRADE OR OTHER NAMES:  3-FMC.
(68) 1-(NAPHTHALEN-2-YL)-2-(PYRROLIDIN-1-YL)PENTAN-1-ONE.   SOME TRADE
OR OTHER NAMES: NAPHYRONE.
(69) ALPHA-PYRROLIDINOBUTIOPHENONE. SOME TRADE OR OTHER NAMES: 2-PBP.
(70) 1-PENTYL-3-(1-NAPHTHOYL)INDOLE.  SOME  TRADE  OR   OTHER   NAMES:
JWH-018 AND AM678.
§  4.  Subdivision  (c)  of  schedule II of section 3306 of the public
(29)   THIAFENTANIL   (4-(METHOXYCARBONYL)-4-(N-   PHENMETHOXYACETAMI-
DO)-1-[2-(THIENYL)ETHYL]PIPERIDINE).
§ 5. Paragraph 63 of subdivision (h) of schedule II of section 3306 of
the  public health law is renumbered paragraph 65 and two new paragraphs
63 and 64 are added to read as follows:
(63) METHASTERONE (2{ALPHA}17{ALPHA}-DIMETHYL-5{ALPHA}-ANDROSTAN-
(64) PROSTANOZOL (17{BETA}-HYDROXY-5{ALPHA}-ANDROSTANO{3,2-C}PYRAZOLE).
§ 6. Subdivision (c) of schedule III of section  3306  of  the  public
health law is amended by adding a new paragraph 15 to read as follows:
§  7.  Subdivision  (c)  of  schedule IV of section 3306 of the public
health law is amended by adding two new paragraphs 54 and 55 to read  as
§  8.  Subdivision  (f)  of  schedule IV of section 3306 of the public
health law, as added by chapter 664 of the laws of 1985, paragraph 2  as
added  by  chapter  457  of the laws of 2006 and paragraph 3 as added by
section 14 of part C of chapter 447 of the laws of 2012, is  amended  to
another  schedule,  any material, compound, mixture or preparation which
contains any quantity of the following substances, including its  salts,
ISOMERS, AND SALTS, OF SUCH ISOMERS:
§  9.  Subdivision  (d)  of  schedule  V of section 3306 of the public
§ 10. This act shall take effect on the ninetieth day after  it  shall